Off-label use of recombinant factor VIIa (rFVIIa) for postoperative hematuria in a factor VII deficient renal transplant patient.

被引：0
|
作者：
Gloster, E
Strauss, R
DaCosta, M
Essex, D
Distant, D
Braverman, A
机构：
[1] SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA
[2] NYU, Sch Med, New York, NY USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4037
引用
收藏
页码：82B / 83B
页数：2
相关论文
共 50 条
  • [21] Off-Label Use of Recombinant Factor VIIa in US Hospitals: Analysis of Hospital Records
    Logan, Aaron C.
    Yank, Veronica
    Stafford, Randall S.
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (08) : 516 - 522
  • [22] Off-label use of recombinant factor VIIa in patients following bone marrow transplantation
    Blatt, J
    Gold, SH
    Wiley, JM
    Monahan, PE
    Cooper, HC
    Harvey, D
    BONE MARROW TRANSPLANTATION, 2001, 28 (04) : 405 - 407
  • [23] Off-label use of recombinant factor VIIa in patients following bone marrow transplantation
    J Blatt
    SH Gold
    JM Wiley
    PE Monahan
    HC Cooper
    D Harvey
    Bone Marrow Transplantation, 2001, 28 : 405 - 407
  • [24] Clinical outcomes of off-label use of recombinant activated factor VII (rFVIIa) at teaching hospitals affiliated with a medical school.
    Cheng, Yijun
    Baxter, Mellisa S.
    Schroeder, Walter S.
    Bernstein, Zale P.
    BLOOD, 2006, 108 (11) : 86B - 86B
  • [25] Six Year, Single Institution, off-Label Use of Recombinant Factor VIIa.
    Patel, Mayur B.
    Bhattacharya, Syamal D.
    Williams, Judson B.
    Sweeney, Timothy E.
    Vaslef, Steven N.
    Hughes, G. Chad
    Kuo, Paul C.
    Lawson, Jeffery H.
    BLOOD, 2010, 116 (21) : 603 - 603
  • [26] Off-label use of recombinant factor VIIa in non-hemophilic patients.
    Culley, CM
    Spiro, RM
    Ragni, MV
    Triulzi, DJ
    Gross, PR
    Guttendorf, S
    Skledar, SJ
    PHARMACOTHERAPY, 2004, 24 (10): : 1437 - 1437
  • [27] Management of thrombosis in a pediatric renal transplant patient with factor VII deficiency A dilemma concerning recombinant factor VIIa
    Yalcin, M.
    Simsek, A.
    Tabel, Y.
    Dogan, S. M.
    Piskin, T.
    ARCHIVES OF HELLENIC MEDICINE, 2020, 37 (03): : 391 - 394
  • [28] SAFETY AND EFFICACY OF OFF-LABEL USE OF RECOMBINANT ACTIVATED FACTOR VII IN CARDIOTHORACIC SURGERY
    Walla, Danielle
    Johnson, Manda
    Baek, Grace
    Schanz, Caitlin
    Pham, Lily
    CRITICAL CARE MEDICINE, 2020, 48
  • [29] Recombinant Activated Factor VII: The Controversial Conundrum Regarding Its Off-Label Use
    Karkouti, Keyvan
    Levy, Jerrold H.
    ANESTHESIA AND ANALGESIA, 2011, 113 (04): : 711 - 712
  • [30] OFF LABEL USE OF RECOMBINANT FACTOR VIIA IN THE HAEMATOLOGY WARD
    Rajic, V.
    Popovic, L.
    Savic, A.
    Savic, I.
    Urosevic, M.
    Zeravica, B.
    Agic, D.
    Vlaisavljevic, N.
    Percic, I.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 680 - 680
12345